Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Jun
1
2021
Panel Discussion Among Government Lawyers Provides Key Insights into the Future of FCA Enforcement Mintz
Jun
1
2021
High Levels of Arsenic and Lead Found in Vinegar Products, Particularly Balsamics Keller and Heckman LLP
Jun
1
2021
FDA Adds Four New Substances to its Inventory of Effective FCS Notifications 2021 Keller and Heckman LLP
Jun
1
2021
DOE Argonne National Laboratory Publishes Retrospective Analysis Of Changes In U.S. Corn Ethanol GHG Emission Intensity Throughout The Years Bergeson & Campbell, P.C.
Jun
1
2021
EC implementation guidelines on the Single-Use Plastics (SUP) directive are finally there…! Keller and Heckman LLP
May
29
2021
EEOC Updates COVID-19 Guidance Regarding Vaccination Incentives, Reasonable Accommodation, and Other Issues Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
May
28
2021
CBD Here, CBD There, CBD Everywhere: Tension Between State and Federal Authorities Leaves CBD Companies in Limbo Strassburger McKenna Gutnick & Gefsky
May
28
2021
Controversy over Online Country of Origin Labeling Keller and Heckman LLP
May
28
2021
CFTC Announces Agricultural Advisory Committee Meeting Katten
May
28
2021
All Things Chemical: TSCA Section 4 and Consortia Formation — A Conversation with Heather Blankinship and Richard Engler, Ph.D. [PODCAST] Bergeson & Campbell, P.C.
May
27
2021
Florida Supreme Court Declares Medical Marijuana Statute’s Vertical Integration Requirement Constitutional and Confirms Caps on Licensees Greenberg Traurig, LLP
May
27
2021
Washington State Seeks Input for 2nd PFAS in Food Packaging Alternative Assessment Keller and Heckman LLP
May
27
2021
Sovereign Wealth Fund Investment in the Global Healthcare Industry McDermott Will & Emery
May
27
2021
Pharmaceutical and Medical Device Manufacturers Be Advised: Sunshine Act / Open Payments Enforcement is on the Rise Mintz
May
27
2021
FDA Warns Companies over Unapproved Fertility Claims Keller and Heckman LLP
May
27
2021
FMCSA Issues Reminder To CDL Drivers Regarding Use Of CBD Products Jackson Lewis P.C.
May
27
2021
DOE Announces Investment In R&D For Plastic Recycling Technologies Bergeson & Campbell, P.C.
May
26
2021
340B Update: HRSA Issues Final Warning Letter to Pharmaceutical Manufacturers that Their Contract Pharmacy Actions Violate 340B Statute K&L Gates
May
26
2021
Agricultural Exemption Does Not Apply to Activities Entirely Away from the Farm Jackson Lewis P.C.
May
26
2021
China’s President Xi Jinping Throws His Support Behind an Intellectual Property Rights Waiver for COVID Vaccines Schwegman, Lundberg & Woessner, P.A.
May
26
2021
FDA Publishes FY20-FY21 Romaine Lettuce Sampling Results Keller and Heckman LLP
May
25
2021
Brain Interfaces Bring Us Closer to a Life of the Mind Womble Bond Dickinson (US) LLP
May
25
2021
Alabama Enacts Medical Marijuana Law Jackson Lewis P.C.
May
25
2021
Oregon Passes Law to Explore Opportunities for Renewable Hydrogen Development K&L Gates
May
25
2021
Whistleblower Exposes Foreign Maker of Medical Devices and its American Affiliate That Paid Kickbacks to Physicians to Prescribe their Devices, Helping the Government Collect $2 Million under the False Claims Act, and the Open Payments Program Tycko & Zavareei LLP
May
25
2021
Flavoring Lawsuit Targets “Hint of Lime” Tostitos Keller and Heckman LLP
May
25
2021
Judge Looks “Kind”ly Upon Certifying Class in Snack Bar Advertising Suit Proskauer Rose LLP
May
25
2021
The Food Safety Aspects of Edible Insects Keller and Heckman LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins